Skip to main content
Clinical Trials/NCT01573871
NCT01573871
Completed
Phase 3

Tolerance and Compliance of Infants Fed an Extensively Hydrolyzed Infant Formula

Abbott Nutrition3 sites in 1 country25 target enrollmentFebruary 2012

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Infant
Sponsor
Abbott Nutrition
Enrollment
25
Locations
3
Primary Endpoint
Weight maintenance
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The objective of the study is to assess gastrointestinal tolerance and compliance in infants who require a hydrolyzed formula.

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
September 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Infant is 0 to 180 days of age
  • Infant with persistent feeding intolerance symptoms; has had at least 1 formula switch OR infant is experiencing/being managed with an extensively hydrolyzed formula for suspected food protein intolerance or allergy or other condition where an extensively hydrolyzed formula is deemed appropriate
  • Infant has not consumed an extensively hydrolyzed infant formula
  • Use of prescription medications, OTC medications, home remedies, herbal preparations or rehydration fluids restricted
  • Infant is not receiving steroids.
  • Parent(s) confirm their intention to feed their infant the study product as the sole source of nutrition for the duration of the study
  • Parent(s) confirm their intention not to administer solid foods or juices to their infant through the duration of the study.
  • Parent(s) confirm their intention not to administer vitamin or mineral during the study

Exclusion Criteria

  • Participation in another study

Outcomes

Primary Outcomes

Weight maintenance

Time Frame: 14 days

Secondary Outcomes

  • Formula volume intake(14 days)

Study Sites (3)

Loading locations...

Similar Trials